Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 19.79 USD 8.74% Market Closed
Market Cap: 71m USD
Have any thoughts about
Aligos Therapeutics Inc?
Write Note

Wall Street
Price Targets

ALGS Price Targets Summary
Aligos Therapeutics Inc

Wall Street analysts forecast ALGS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALGS is 68.85 USD with a low forecast of 60.6 USD and a high forecast of 78.75 USD.

Lowest
Price Target
60.6 USD
206% Upside
Average
Price Target
68.85 USD
248% Upside
Highest
Price Target
78.75 USD
298% Upside
Aligos Therapeutics Inc Competitors:
Price Targets
688278
Xiamen Amoytop Biotech Co Ltd
3% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
29% Upside
SPRY
ARS Pharmaceuticals Inc
108% Upside
ZNTL
Zentalis Pharmaceuticals Inc
200% Upside
4882
Perseus Proteomics Inc
13% Upside
CANTA
Cantargia AB
389% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
27% Upside
LCTX
Lineage Cell Therapeutics Inc
684% Upside

Revenue
Forecast

Revenue Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALGS's stock price target?
Price Target
68.85 USD

According to Wall Street analysts, the average 1-year price target for ALGS is 68.85 USD with a low forecast of 60.6 USD and a high forecast of 78.75 USD.

Back to Top